Target Name: POU2F1
NCBI ID: G5451
Other Name(s): PO2F1_HUMAN | POU domain, class 2, transcription factor 1 (isoform 1) | POU class 2 homeobox 1, transcript variant 1 | oct-1 | OCT1 | OTF1 | OTF-1 | Octamer-binding transcription factor-1 | NF-A1 | POU2F1 variant 1 | Octamer-binding protein 1 | Oct-1 | octamer-binding transcription factor 1 | POU class 2 homeobox 1 | oct-1B | octamer-binding protein 1 | Octamer-binding transcription factor 1 | Oct1Z | POU domain, class 2, transcription factor 1 | BOB1

POU2F1: A Drug Target / Disease Biomarker

POU2F1, also known as protamineuron, is a gene that has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

The POU2F1 gene is located on chromosome 16 and encodes a protein known as protamineuron, which is a key regulator of microRNA (miRNA) levels in the body. MicroRNAs are small non-coding RNAs that play a critical role in post-transcriptional gene regulation by regulating the translation of mRNAs into proteins.

Studies have shown that POU2F1 is involved in the regulation of a wide range of genes, including those involved in cancer, neurodegenerative diseases, and psychiatric disorders. For example, studies have found that high levels of POU2F1 are associated with an increased risk of cancer, and that POU2F1 knockdown has been shown to protect against cancer in both humans and animals.

In addition to its potential as a cancer drug target, POU2F1 has also been shown to be involved in the regulation of other biological processes, including cell signaling, cell division, and neurodegeneration. For example, studies have shown that POU2F1 is involved in the regulation of mitochondrial function and that POU2F1 knockdown has been shown to increase the risk of neurodegenerative diseases.

In addition to its potential as a drug target or biomarker, POU2F1 has also been shown to be involved in the regulation of various psychiatric disorders. For example, studies have shown that POU2F1 is involved in the regulation of anxiety and that POU2F1 knockdown has been shown to reduce anxiety in both humans and animals.

Overall, the POU2F1 gene has a wide range of potential applications as a drug target or biomarker, due to its involvement in the regulation of a wide range of biological processes and its association with several diseases. Further research is needed to fully understand the role of POU2F1 in these processes and to develop safe and effective drugs or other treatments based on POU2F1.

Protein Name: POU Class 2 Homeobox 1

Functions: Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3') and activates the promoters of the genes for some small nuclear RNAs (snRNA) and of genes such as those for histone H2B and immunoglobulins. Modulates transcription transactivation by NR3C1, AR and PGR

More Common Targets

POU2F2 | POU2F3 | POU3F1 | POU3F2 | POU3F3 | POU3F4 | POU4F1 | POU4F2 | POU4F3 | POU5F1 | POU5F1B | POU5F1P3 | POU5F1P4 | POU5F1P5 | POU5F2 | POU6F1 | POU6F2 | PP12613 | PP2D1 | PP7080 | PPA1 | PPA2 | PPAN | PPAN-P2RY11 | PPARA | PPARD | PPARG | PPARGC1A | PPARGC1B | PPAT | PPATP1 | PPBP | PPBPP2 | PPCDC | PPCS | PPDPF | PPDPFL | PPEF1 | PPEF2 | PPFIA1 | PPFIA2 | PPFIA3 | PPFIA4 | PPFIBP1 | PPFIBP2 | PPHLN1 | PPIA | PPIAL4A | PPIAL4D | PPIAL4E | PPIAL4F | PPIAL4G | PPIAL4H | PPIAP19 | PPIAP21 | PPIAP22 | PPIAP29 | PPIAP30 | PPIAP35 | PPIAP43 | PPIAP45 | PPIAP46 | PPIAP51 | PPIAP54 | PPIAP59 | PPIAP66 | PPIAP7 | PPIAP74 | PPIAP8 | PPIAP80 | PPIAP9 | PPIB | PPIC | PPID | PPIE | PPIEL | PPIF | PPIG | PPIH | PPIL1 | PPIL2 | PPIL3 | PPIL4 | PPIL6 | PPIP5K1 | PPIP5K2 | PPL | PPM1A | PPM1B | PPM1D | PPM1E | PPM1F | PPM1G | PPM1H | PPM1J | PPM1K | PPM1K-DT | PPM1L | PPM1M | PPM1N